Work

Dupilumab‐Induced Psoriasis in a Patient with Bullous Pemphigoid

Year: 2026
Type: article
Abstract: JK has received honoraria from Bristol-Myers Squibb, UCB, Sun Pharma, Sanofi, Novartis, Beiersdorf AG, doctorderma Online Hautarzt and Melatech, outside the submitted work. JK has received travel support from SUN Pharma and Pierre Fabre, outside the submitted work. FA and IHA received speaker fees from Sanofi, outside the submitted work. The other authors declare no conflict of interest.
Language: English
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $4,480
OpenAlex ID: W7160633030
FWCI: 9.109
Cites: 8
Cited by: 2
Related to: